Skip to main content
JoAnne Foody, MD, Cardiology, Boston, MA

JoAnne M Foody MD

Cardiology•Boston, MA

Associate Professor of Medicine, Brigham and Women's Hospital

Join to View Full Profile

  • 75 Francis StBoston, MA 02115

  • Phone+1 857-307-1989

  • Fax+1 857-307-1955

Dr. Foody is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Foody's Full ProfileAlready have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1996 - 2000
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1992 - 2026

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Whos Who in Medicine and Healthcare Marquis Whos Who
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Lectures

  • Preventive Cardiology Issues in Primary Care - CME Getaways Santa Monica 
    CME Getaways, New York, New York - 9/14/2012
  • 6th Annual Heart of Womens Health 
    American College of Cardiology Foundation, Washington, Dist Of Col - 1/20/2012

Press Mentions

  • European Commission Approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)
    European Commission Approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)September 30th, 2024
  • Landmark CLEAR Outcomes Study Demonstrates NEXLETOL (Bempedoic Acid) Tablet Is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad Population
    Landmark CLEAR Outcomes Study Demonstrates NEXLETOL (Bempedoic Acid) Tablet Is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad PopulationApril 3rd, 2023
  • LDL May Be an Alternative to Statins
    LDL May Be an Alternative to StatinsMarch 5th, 2023
  • Join now to see all

Grant Support

  • Lipid Testing /Treatment In Older MI PatientsNational Institute On Aging2002–2005

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. JoAnne Foody, Dr. JoAnne Foody, MD, Dr. J Foody, Dr. JoAnne M Foody